Search research articles
Contact Us
Filters
Showing results (51-60 of 177) with videos related to
Page
of 18
Sort By:
The Journal of Trauma
|
January 6, 2006
Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients
Curtis E Haas, Jamie L Nelsen, Krishnan Raghavendran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2013
Reply to Pai
Cornelia B Landersdorfer, Roger L Nation, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy
|
June 30, 2010
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model
Phillip J Bergen, Jurgen B Bulitta, Alan Forrest, et al.
The Journal of Infectious Diseases
|
December 17, 2009
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes
Pamela A Moise, Alan Forrest, Arnold S Bayer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 1, 2004
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
Pamela A Moise-Broder, George Sakoulas, George M Eliopoulos, et al.
Diagnostic Microbiology and Infectious Disease
|
June 28, 2008
Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia
Sujata M Bhavnani, Alan Forrest, Jeffrey P Hammel, et al.
Antimicrobial Agents and Chemotherapy
|
October 15, 2008
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa
Jürgen B Bulitta, Neang S Ly, Jenny C Yang, et al.
Journal of Intensive Care Medicine
|
June 11, 2008
A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients
Jamie L Nelsen, Curtis E Haas, Bahru Habtemariam, et al.
Plos One
|
June 11, 2016
Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach
Samira M Garonzik, Justin R Lenhard, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2009
Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia
Christopher M Rubino, Scott A Van Wart, Sujata M Bhavnani, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 177) with videos related to
Sort By:
Page
of 18
The Journal of Trauma
|
January 6, 2006
Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients
Curtis E Haas, Jamie L Nelsen, Krishnan Raghavendran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2013
Reply to Pai
Cornelia B Landersdorfer, Roger L Nation, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy
|
June 30, 2010
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model
Phillip J Bergen, Jurgen B Bulitta, Alan Forrest, et al.
The Journal of Infectious Diseases
|
December 17, 2009
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes
Pamela A Moise, Alan Forrest, Arnold S Bayer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 1, 2004
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
Pamela A Moise-Broder, George Sakoulas, George M Eliopoulos, et al.
Diagnostic Microbiology and Infectious Disease
|
June 28, 2008
Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia
Sujata M Bhavnani, Alan Forrest, Jeffrey P Hammel, et al.
Antimicrobial Agents and Chemotherapy
|
October 15, 2008
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa
Jürgen B Bulitta, Neang S Ly, Jenny C Yang, et al.
Journal of Intensive Care Medicine
|
June 11, 2008
A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients
Jamie L Nelsen, Curtis E Haas, Bahru Habtemariam, et al.
Plos One
|
June 11, 2016
Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach
Samira M Garonzik, Justin R Lenhard, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2009
Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia
Christopher M Rubino, Scott A Van Wart, Sujata M Bhavnani, et al.
Page
of 18